Neuralstem Inc. (CUR)

1.69
NASDAQ : Health Technology
Prev Close 1.67
Day Low/High 1.57 / 1.74
52 Wk Low/High 1.50 / 24.40
Avg Volume 159.10K
Exchange NASDAQ
Shares Outstanding 2.10M
Market Cap 3.51M
EPS -6.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current levels.

3 Biotech Stocks Under $10 to Watch

3 Biotech Stocks Under $10 to Watch

Keep these under-$10 biotech stocks on your radar.

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look poised to trade higher from current levels.

4 Biotech Stocks Under $10 Moving Higher

4 Biotech Stocks Under $10 Moving Higher

If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

4 Biotech Stocks Under $10 Moving Higher

4 Biotech Stocks Under $10 Moving Higher

Stocks that are making large moves are favorites among short-term traders because they can try to capture some of that massive volatility.

Stocks Close Week Higher on QE3 Confidence

Stocks Close Week Higher on QE3 Confidence

The Dow rises for the eighth time in the past ten weeks and bonds plunge as the Fed's bold easing plan whets investor appetite for risk.

5 Stocks Under $10 Setting Up to Break Out

5 Stocks Under $10 Setting Up to Break Out

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin.

5 Stocks Poised for Big Breakouts

5 Stocks Poised for Big Breakouts

These stocks look ready to break out and trade higher from current levels.

9 Biotech Penny Stocks to Buy

9 Biotech Penny Stocks to Buy

These cheap healthcare companies trading for less than $3 a share have big upside potential for September as volume picks up on Wall Street.

Interstate Hotels, Neuralstem: Midday Volume Plays

Several stocks trading near $5 were moving on above-average volume during Friday's session.

Four Must-See Charts: Stem Cell Stocks

Four Must-See Charts: Stem Cell Stocks

These stem cell stocks could be setting up to make a big move.

Stem cell firms jump on Obama policy plans

Stem cell developers surge on plans to reverse Bush research funding restrictions

Wednesday's Health Winners & Losers

Allergan rises on a deal to buy privately held Esprit Pharma.

TheStreet Quant Rating: D- (Sell)